Sujentec Launches 'Surely Smart,' Korea's First Digital Healthcare for Female Hormone Diagnosis

Four types of SuzenTec's 'Surely Smart'. [Photo by SuzenTec]

[Asia Economy Reporter Lee Gwan-joo] Suzentec announced on the 7th that it will launch 'Surely Smart,' the first domestic digital healthcare product for female hormone diagnosis.

Surely Smart is a product that can manage the entire cycle of female hormones. It is an in vitro diagnostic medical device certified to diagnose a total of five female hormones: ovulation, pregnancy, menopause, estrogen, and progesterone.

It features a portable digital device that connects with a mobile application (app). Hormones can be measured within 10 minutes through urine, and hormone patterns can be managed. Test results can be clearly confirmed digitally, and a service that allows continuous monitoring through the mobile app is supported.

A Suzentec official stated, "Surely Smart is a female hormone diagnostic product that allows periodic self-diagnosis and management of physical changes caused by hormone fluctuations," adding, "Starting with the launch of our smart store in December, we plan to sequentially enter open markets, convenience stores, and health & beauty drugstores to expand our business into various areas such as cosmetics and health functional foods."

He continued, "Surely Smart is a home test platform prepared even before COVID-19 and is one of the items for future sustainable growth. We will fully develop the home test platform, as well as lab test and clinic test platforms, to transform into a digital healthcare company."

This content was produced with the assistance of AI translation services.